<!DOCTYPE html>
<html lang="en">
	<head>
  		<meta charset="UTF-8">
  		<title>Bio2RDF - Drugbank</title>
		<link href="images/bio2rdf.png" rel="shortcut icon" />
		<link rel="stylesheet" type="text/css" href="css/style.css" media="screen" />
  		<script src="https://code.jquery.com/jquery-3.2.1.min.js"></script>
  		<script src="handlebars-v4.0.10.js"></script>
  		<!--<script src="https://cdnjs.cloudflare.com/ajax/libs/handlebars.js/4.0.10/handlebars.runtime.min.js"></script>-->
	
		<script type="application/ld+json">{
 "@context" : "http://schema.org",
  "@id" : "http://bio2rdf.org/drugbank:DB00238",
  "@type" : "Drug",
  "administrationRoute" : "oral",
  "availableStrength" : [ {
    "@id" : "http://bio2rdf.org/drugbank_resource:367675b1ffd6562f2341d50e0f7b57b8",
    "@type" : "DrugStrength",
    "description" : "400 mg Tablet, extended release form with oral route"
  }, {
    "@id" : "http://bio2rdf.org/drugbank_resource:74c52bc20330cf019f62fddf0ee2c035",
    "@type" : "DrugStrength",
    "description" : "100 mg Tablet, extended release form with oral route"
  }, {
    "@id" : "http://bio2rdf.org/drugbank_resource:4def2f1dce2ec74ca9c13a998a4e8bd1",
    "@type" : "DrugStrength",
    "description" : "200 mg Tablet form with oral route"
  }, {
    "@id" : "http://bio2rdf.org/drugbank_resource:18d867dbbf0fc70b5b2b54a78753b2f4",
    "@type" : "DrugStrength",
    "description" : "50 mg/5mL Suspension form with oral route"
  } ],
  "clinicalPharmacology" : "Nevirapine is a non-nucleoside reverse transcriptase inhibitor (nNRTI) with activity against Human Immunodeficiency Virus Type 1 (HIV-1). HIV-2 RT and eukaryotic DNA polymerases (such as human DNA polymerases alpha, beta, or sigma) are not inhibited by nevirapine. Nevirapine is, in general, only prescribed after the immune system has declined and infections have become evident. It is always taken with at least one other HIV medication such as Retrovir or Videx. The virus can develop resistance to nevirapine if the drug is taken alone, although even if used properly, nevirapine is effective for only a limited time.",
  "cost" : {
    "@id" : "http://bio2rdf.org/drugbank_resource:169f6d8b0ad6082b63b68bbd2422c430",
    "@type" : "DrugCost",
    "costCurrency" : "USD",
    "costPerUnit" : [ "9.3000001907348632812", "9.479999542236328125" ],
    "drugUnit" : "Viramune 200 mg tablet"
  },
  "description" : "A potent, non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with nucleoside analogues for treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection and AIDS. [PubChem] Structurally, nevirapine belongs to the dipyridodiazepinone chemical class.",
  "dosageForm" : [ "Tablet, extended release", "Suspension", "Tablet" ],
  "drugClass" : [ "Reverse Transcriptase Inhibitors", "Anti-HIV Agents" ],
  "foodWarning" : "Avoid alcohol.",
  "identifier" : "drugbank:DB00238",
  "interactingDrug" : [ "DDI between Nevirapine and Hydrocodone - CYP3A4 Inducers (Weak) may decrease the serum concentration of Hydrocodone.", "DDI between Nevirapine and Efavirenz - May enhance the adverse/toxic effect of Nevirapine. Nevirapine may enhance the adverse/toxic effect of Efavirenz. Nevirapine may decrease the serum concentration of Efavirenz.", "DDI between Nevirapine and Pimozide - CYP3A4 Inhibitors (Weak) may increase the serum concentration of Pimozide.", "DDI between Nevirapine and Siltuximab - May decrease the serum concentration of CYP3A4 Substrates.", "DDI between Nevirapine and Aripiprazole - CYP3A4 Inducers may decrease the serum concentration of ARIPiprazole.", "DDI between Nevirapine and Medroxyprogesterone Acetate - May decrease the serum concentration of Contraceptives (Progestins).", "DDI between Nevirapine and Tocilizumab - May decrease the serum concentration of CYP3A4 Substrates.", "DDI between Nevirapine and Desogestrel - May decrease the serum concentration of Contraceptives (Estrogens).", "DDI between Nevirapine and Rifabutin - Nevirapine may decrease the serum concentration of Rifabutin. Nevirapine may increase the serum concentration of Rifabutin. Rifabutin may decrease the serum concentration of Nevirapine.", "DDI between Nevirapine and Mestranol - May decrease the serum concentration of Contraceptives (Estrogens).", "DDI between Nelfinavir and Nevirapine - May decrease serum concentrations of the active metabolite(s) of Nelfinavir. Nevirapine may decrease the serum concentration of Nelfinavir.", "DDI between Dofetilide and Nevirapine - CYP3A4 Inhibitors (Weak) may increase the serum concentration of Dofetilide.", "DDI between Nevirapine and Dolutegravir - Nevirapine may decrease the serum concentration of Dolutegravir.", "DDI between Nevirapine and Etonogestrel - May decrease the serum concentration of Contraceptives (Progestins).", "DDI between Nevirapine and Carbamazepine - May decrease the serum concentration of Reverse Transcriptase Inhibitors (Non-Nucleoside). Reverse Transcriptase Inhibitors (Non-Nucleoside) may decrease the serum concentration of CarBAMazepine. This mechanism applies specifically to efavirenz.", "DDI between Nevirapine and Norgestimate - May decrease the serum concentration of Contraceptives (Progestins).", "DDI between Nevirapine and Voriconazole - May increase the serum concentration of Reverse Transcriptase Inhibitors (Non-Nucleoside). Reverse Transcriptase Inhibitors (Non-Nucleoside) may decrease the serum concentration of Voriconazole.", "DDI between Fluconazole and Nevirapine - Fluconazole may increase the serum concentration of Nevirapine.", "DDI between Nevirapine and Etravirine - Reverse Transcriptase Inhibitors (Non-Nucleoside) may decrease the serum concentration of Etravirine. This has been observed with the NNRTIs efavirenz and nevirapine. Reverse Transcriptase Inhibitors (Non-Nucleoside) may increase the serum concentration of Etravirine. This has been observed with delavirdine.", "DDI between Nevirapine and Levonorgestrel - May decrease the serum concentration of Contraceptives (Progestins).", "DDI between Nevirapine and Deferasirox - May decrease the serum concentration of CYP3A4 Substrates.", "DDI between Nevirapine and Norethindrone - May decrease the serum concentration of Contraceptives (Progestins).", "DDI between Nevirapine and Darunavir - May increase the serum concentration of Nevirapine. Nevirapine may increase the serum concentration of Darunavir.", "DDI between Nevirapine and Caspofungin - Inducers of Drug Clearance may decrease the serum concentration of Caspofungin.", "DDI between Nevirapine and Lumefantrine - May decrease the serum concentration of Artemether. Nevirapine may also increase or decrease serum concentrations of lumefantrine.", "DDI between Indinavir and Nevirapine - May decrease the serum concentration of Indinavir.", "DDI between Nevirapine and Ethynodiol - May decrease the serum concentration of Contraceptives (Estrogens).", "DDI between Nevirapine and Lopinavir - Nevirapine may decrease the serum concentration of Lopinavir.", "DDI between Nevirapine and Rifampicin - Rifampin may decrease the serum concentration of Nevirapine.", "DDI between Nevirapine and Ethinyl Estradiol - May decrease the serum concentration of Contraceptives (Estrogens).", "DDI between Nevirapine and Artemether - Nevirapine may decrease the serum concentration of Artemether. Nevirapine may also increase or decrease serum concentrations of lumefantrine.", "DDI between Nevirapine and Atazanavir - May increase the serum concentration of Nevirapine. Nevirapine may decrease the serum concentration of Atazanavir.", "DDI between Nevirapine and Saquinavir - Nevirapine may decrease the serum concentration of Saquinavir.", "DDI between Nevirapine and Itraconazole - Nevirapine may decrease the serum concentration of Itraconazole.", "DDI between Nevirapine and Norelgestromin - May decrease the serum concentration of Contraceptives (Estrogens).", "DDI between Nevirapine and Dabrafenib - May decrease the serum concentration of CYP3A4 Substrates.", "DDI between Nevirapine and Drospirenone - May decrease the serum concentration of Contraceptives (Progestins).", "DDI between Nevirapine and Methadone - Reverse Transcriptase Inhibitors (Non-Nucleoside) may increase the metabolism of Methadone.", "DDI between Nevirapine and Saxagliptin - CYP3A4 Inducers may decrease the serum concentration of Saxagliptin.", "DDI between Nevirapine and Lomitapide - CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.", "DDI between Nevirapine and Fosamprenavir - Nevirapine may decrease serum concentrations of the active metabolite(s) of Fosamprenavir.", "DDI between Nevirapine and Rilpivirine - Reverse Transcriptase Inhibitors (Non-Nucleoside) may increase the serum concentration of Rilpivirine. This mechanism applies to coadministration of delavirdine. Reverse Transcriptase Inhibitors (Non-Nucleoside) may decrease the serum concentration of Rilpivirine. This mechanism applies to coadministration of efavirenz, etravirine, and nevirapine.", "DDI between Nevirapine and Mitotane - May decrease the serum concentration of CYP3A4 Substrates.", "DDI between Nevirapine and Bosentan - May decrease the serum concentration of CYP3A4 Substrates." ],
  "legalStatus" : "Approved",
  "manufacturer" : {
    "@id" : "http://bio2rdf.org/drugbank_resource:3a7e3ffd9ccb53b1eb2d24cd6753805e",
    "@type" : "Organization",
    "name" : "Boehringer ingelheim pharmaceuticals inc"
  },
  "mechanismOfAction" : "Nevirapine binds directly to reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by causing a disruption of the enzyme's catalytic site. The activity of nevirapine does not compete with template or nucleoside triphosphates.",
  "name" : "Nevirapine",
  "nonProprietaryName" : [ "Viramune", "Nevirapine", "11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one", "NVP", "NEV" ],
  "proprietaryName" : "Viramune XR",
  "sameAs" : [ "http://www.drugbank.ca/drugs/DB00238", "http://www.rxlist.com/cgi/generic2/nevira.htm", "http://www.drugs.com/cdi/nevirapine.html" ],
  "url" : "https://schemaorg.metadatacenter.org/drugbank/DB00238.html"
}</script>
	</head>

	<body>
		<br/><br/>
		
		<div id="all">
	 		<div id="main" style="text-align: center;">
	 			<div style="height: 20%;">&nbsp;</div>
	 			<img alt="Drugbank" src="images/drugbank.png" />
	 			<div id="main" style="text-align: center;">
	 				<em>Bio2RDF Drugbank Data</em>
				</div>

				<br/><br/>

			</div>

			<div id="contents">
				<script type="text/javascript">

				var templateCode = "<table><tbody><tr><td class='dataframeKey'>Drug Name</td><td>{{name}}</td></tr><tr><td class='dataframeKey'>Description</td><td>{{description}}</td></tr><tr><td class='dataframeKey'>Identifier</td><td>{{schema:identifier}}</td></tr><tr><td class='dataframeKey'>Non-Proprietary Names</td><td><ul>{{#each nonProprietaryName}}<li>{{this}}</li>{{else}}{{nonProprietaryName}}{{/each}}</ul></td></tr><tr><td class='dataframeKey'>Proprietary Name</td><td>{{proprietaryName}}</td></tr><tr><td class='dataframeKey'>Drug Classes</td><td><ul>{{#each drugClass}}<li>{{this}}</li>{{else}}{{drugClass}}{{/each}}</ul></td></tr><tr><td class='dataframeKey'>Clinical Pharmacology</td><td>{{clinicalPharmacology}}</td></tr><tr><td class='dataframeKey'>Manufacturer</td><td>{{#with manufacturer}}{{name}}{{/with}}</td></tr><tr><td class='dataframeKey'>Mechanism of Action</td><td>{{mechanismOfAction}}</td></tr><tr><td class='dataframeKey'>Food Warning</td><td>{{foodWarning}}</td></tr><tr><td class='dataframeKey'>URL</td><td><a href='{{schema:url}}'>{{schema:url}}</a></td></tr><tr><td class='dataframeKey'>Costs</td><td>{{#if cost.length}}<ul>{{#each cost}}<li>{{#with this}}{{drugUnit}} - {{costPerUnit}}{{costCurrency}}{{/with}}</li>{{/each}}</ul>{{else}}{{#with cost}}{{drugUnit}} - {{costPerUnit}}{{costCurrency}}{{/with}}{{/if}}</td></tr><tr><td class='dataframeKey'>Available Strength</td><td>{{#if availableStrength.length}}<ul>{{#each availableStrength}}<li>{{this.description}}</li>{{/each}}</ul>{{else}}{{#with availableStrength}}{{description}}{{/with}}{{/if}}</td></tr><tr><td class='dataframeKey'>Dosage Forms</td><td><ul>{{#each dosageForm}}<li>{{this}}</li>{{else}}{{dosageForm}}{{/each}}</ul></td></tr><tr><td class='dataframeKey'>Administration Route</td><td><ul>{{#each administrationRoute}}<li>{{this}}</li>{{else}}{{administrationRoute}}{{/each}}</ul></td></tr><tr><td class='dataframeKey'>Interacting Drugs</td><td><ul>{{#each interactingDrug}}<li>{{this}}</li>{{else}}{{interactingDrug}}{{/each}}</ul></td></tr><tr><td class='dataframeKey'>Legal Statuses</td><td><ul>{{#each legalStatus}}<li>{{this}}</li>{{else}}{{legalStatus}}{{/each}}</ul></td></tr><tr><td class='dataframeKey'>Same As</td><td><ul>{{#each sameAs}}<li><a href='{{this}}'>{{this}}</a></li>{{else}}<a href='{{sameAs}}'>{{sameAs}}</a>{{/each}}</ul></td></tr></tbody></table>";
				var template = Handlebars.compile(templateCode);

				$.getJSON("jsonld/DB00238.json", function(data) {
			    	document.getElementById("contents").innerHTML += template(data);
				});
		
				</script>
			</div>
		</div>
	</body>
</html>